MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
BRNS Barinthus Biotherapeutics
- 1.110
- +0.090+8.82%
Close Dec 20 16:00 ET
- 1.160
- +0.050+4.50%
Post 20:01 ET
44.65MMarket Cap-0.74P/E (TTM)
1.114High1.020Low36.41KVolume1.050Open1.020Pre Close38.68KTurnover0.13%Turnover RatioLossP/E (Static)40.23MShares4.15952wk High0.28P/B31.27MFloat Cap0.80152wk Low--Dividend TTM28.17MShs Float17.990Historical High--Div YieldTTM9.26%Amplitude0.801Historical Low1.062Avg Price1Lot Size
Barinthus Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -62.61%-18.2M | 29.20%-12.01M | -272.46%-11.82M | -252.89%-50.93M | -72.82%-19.6M | -194.17%-11.19M | -102.04%-16.96M | 51.76%-3.17M | 55.71%-14.43M | -42.29%-11.34M |
| Net income from continuing operations | 42.39%-8.13M | 28.88%-16.94M | 14.83%-15.52M | -1,480.32%-73.45M | 18.30%-17.29M | -271.63%-14.11M | -251.85%-23.82M | -807.96%-18.22M | 110.41%5.32M | -39.50%-21.16M |
| Operating gains losses | 141.73%2.61M | -87.76%443K | -129.28%-1.03M | 129.82%7.53M | -43.01%6.65M | 65.69%-6.24M | --3.62M | --3.5M | -432.89%-25.25M | --11.67M |
| Depreciation and amortization | 0.07%1.48M | 12.93%1.47M | 17.12%1.43M | 25.58%5.43M | 21.92%1.44M | 24.07%1.47M | 30.95%1.3M | 26.40%1.22M | 618.11%4.32M | 266.67%1.18M |
| Deferred tax | 99.50%-3K | 99.38%-7K | 92.83%-37K | 29.10%-3.08M | 57.55%-821K | 3.68%-602K | -24.15%-1.14M | 40.21%-516K | -3,544.54%-4.34M | -3,292.98%-1.93M |
| Other non cash items | 108.33%2K | -30.87%383K | 18.41%431K | 21.43%1.41M | 191.18%517K | -104.17%-24K | -28.15%554K | -4.96%364K | 0.96%1.16M | -262.93%-567K |
| Change In working capital | -285.20%-15.29M | 168.63%1.46M | -84.43%1.29M | 211.71%6.17M | -323.42%-10.88M | -57.91%8.26M | 106.06%542K | 160.59%8.25M | 23.04%-5.52M | -185.47%-2.57M |
| -Change in receivables | -1,510.14%-15.55M | 429.46%683K | -104.69%-331K | 221.35%5.67M | -270.68%-553K | -108.30%-966K | -68.69%129K | 141.42%7.06M | -53.38%-4.68M | 145.06%324K |
| -Change in prepaid assets | -14.99%1.82M | -64.09%-1.61M | -54.16%1.88M | 201.38%2.2M | -491.40%-3.05M | -30.25%2.14M | 79.93%-983K | 464.85%4.09M | 48.59%-2.17M | -38.81%779K |
| -Change in payables and accrued expense | -131.23%-2.28M | 150.11%3.45M | 55.43%-1.35M | -173.24%-1.39M | -112.12%-7.04M | 48.21%7.29M | 132.26%1.38M | -166.14%-3.02M | 112.71%1.89M | -235.00%-3.32M |
| -Change in other current assets | --0 | --0 | --0 | 133.07%128K | 193.06%201K | ---211K | 108.98%15K | 3,175.00%123K | 47.35%-387K | -2,063.64%-216K |
| -Change in other current liabilities | ---487K | ---473K | ---346K | ---445K | ---445K | --0 | --0 | --0 | --0 | ---- |
| -Change in other working capital | --1.21M | ---595K | --1.43M | ---- | ---- | ---- | ---- | ---- | -190.48%-183K | -833.33%-140K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -62.61%-18.2M | 29.20%-12.01M | -272.46%-11.82M | -252.89%-50.93M | -72.82%-19.6M | -194.17%-11.19M | -102.04%-16.96M | 51.76%-3.17M | 55.71%-14.43M | -42.29%-11.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -216.67%-114K | 93.65%-192K | 87.71%-308K | 5.86%-5.41M | 126.11%153K | 98.22%-36K | -47.18%-3.02M | -129.58%-2.51M | 55.47%-5.75M | 95.19%-586K |
| Net PPE purchase and sale | -216.67%-114K | 93.65%-192K | 87.71%-308K | 5.86%-5.41M | 126.11%153K | 98.22%-36K | -47.18%-3.02M | -129.58%-2.51M | -401.75%-5.75M | -38.21%-586K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -216.67%-114K | 93.65%-192K | 87.71%-308K | 5.86%-5.41M | 126.11%153K | 98.22%-36K | -47.18%-3.02M | -129.58%-2.51M | 55.47%-5.75M | 95.19%-586K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 910.87%465K | 1,178.57%358K | -70.22%503K | 476.00%1.87M | -77.48%109K | 46K | 28K | 1,162.26%1.69M | -99.85%325K | 5,277.78%484K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---159K | --0 |
| Net common stock issuance | 910.87%465K | 293.41%358K | -71.88%503K | 320.45%2.04M | -77.48%109K | --46K | --91K | --1.79M | -99.53%484K | 268.64%484K |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---- | ---- | ---- | ---163K | --0 | --0 | ---63K | ---100K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 910.87%465K | 1,178.57%358K | -70.22%503K | 476.00%1.87M | -77.48%109K | --46K | --28K | 1,162.26%1.69M | -99.85%325K | 5,277.78%484K |
| Net cash flow | ||||||||||
| Beginning cash position | -31.93%117.77M | -32.07%129.97M | -26.90%142.09M | -9.19%194.39M | -19.89%160.31M | -10.03%173.03M | -4.62%191.33M | -9.19%194.39M | 394.74%214.05M | -14.44%200.1M |
| Current changes in cash | -59.62%-17.85M | 40.66%-11.84M | -191.26%-11.63M | -174.30%-54.47M | -68.99%-19.34M | -213.33%-11.18M | -90.98%-19.95M | 49.02%-3.99M | -111.20%-19.86M | 43.21%-11.45M |
| Effect of exchange rate changes | 500.97%6.18M | -121.58%-357K | -152.62%-492K | 1,060.96%2.17M | -80.41%1.12M | 26.28%-1.54M | -24.06%1.65M | 116.61%935K | 102.90%187K | 1,604.17%5.73M |
| End cash Position | -33.81%106.1M | -31.93%117.77M | -32.07%129.97M | -26.90%142.09M | -26.90%142.09M | -19.89%160.31M | -10.03%173.03M | -4.62%191.33M | -9.19%194.39M | -9.19%194.39M |
| Free cash flow | -63.11%-18.31M | 38.95%-12.2M | -113.52%-12.13M | -173.90%-56.34M | -63.05%-19.45M | -218.45%-11.23M | -91.25%-19.98M | 25.94%-5.68M | 39.02%-20.57M | -42.08%-11.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.